Chewy Inc. (CHWY) shares tumbled to a 52-week low of under $20 on Thursday, extending the year-to-date decline to nearly 40%, after the company reported fiscal first-quarter earnings that fell short of analyst expectations and issued cautious guidance. The sell-off reflects investor concern over CEO Sumit Singh's recent remarks that U.S. consumers are increasingly "stretched" due to resurgent inflationary pressures, leading to reduced spending on discretionary pet items like toys and accessories.
Q1 Earnings: A Mixed Picture
For the quarter ended April 30, Chewy posted revenue of $2.86 billion, up 7.7% year-over-year, and gross margin improved by 50 basis points to 30.1%. Adjusted EBITDA rose $60 million from the prior-year period. However, earnings per share missed consensus estimates, and the company's forward guidance signaled continued headwinds in the current quarter, prompting a wave of selling.
Despite the earnings miss, the underlying business remains fundamentally sound. Revenue growth, margin expansion, and EBITDA improvement are not the hallmarks of a company in distress. Yet the stock is being priced as one, trading at just 0.67 times sales—a valuation that appears deeply discounted relative to its growth trajectory.
Autoship Program: A Recurring Revenue Anchor
A key pillar of Chewy's resilience is its Autoship subscription program, which generates predictable, recurring revenue from essential pet supplies such as food and medicine. These items are largely non-discretionary, making the core business relatively recession-resistant. While customers may cut back on toys and accessories during periods of economic uncertainty, the Autoship-driven revenue stream remains sticky and difficult for competitors to replicate.
Chewy's expansion into pet healthcare, including Vet Care clinics and its pharmacy/prescription business, represents an underappreciated growth vector. As this segment scales, it broadens the company's addressable market and deepens customer loyalty beyond the commodity grocery and supplies business. Over time, this could serve as a catalyst for stock price appreciation.
Macro Headwinds Are Temporary
Investors should view the current macroeconomic weakness as cyclical rather than structural. Pet spending has historically proven resilient through economic downturns; when inflation eases, discretionary pet spending tends to rebound quickly. Singh's cautious commentary reflects the present inflationary environment, not a permanent shift in consumer behavior toward pet ownership.
At current levels, Chewy offers a premium business at a trough valuation tied to a temporary macro cycle. Additionally, the gradual exit of co-founder Ryan Cohen, who has been a persistent seller of CHWY shares for years, is reducing a significant overhang on the stock. As that selling pressure diminishes, the technical ceiling that has suppressed the stock's recovery may lift.
Wall Street Remains Bullish
Despite the near-term headwinds, the consensus rating on Chewy stock remains a "Strong Buy," with a mean price target of $40—implying potential upside of roughly 100% from current levels. For long-term investors, the post-earnings decline may represent a compelling entry point into a company with strong fundamentals, a durable subscription model, and expanding healthcare offerings.
For context on broader market dynamics, see our coverage of 5 Stocks Drawing Heightened Institutional Interest Ahead of Key Earnings Week and Netflix Stock Falls 10% as Q1 Results Disappoint on Three Key Investor Expectations.
This article is for informational purposes only and does not constitute financial advice.
